During the Resistance Stage, continued activity in the sympathetic nervous system and hypothalamic-pituitary-adrenal axis keeps stress hormones, including cortisol, elevated while the person faces ongoing demands. This sustained signaling helps preserve short-term performance and coping rather than ending after the initial reaction. Its significance is that adaptation carries a physiological cost when the stressor remains present.
An important distinction is duration and consequence. The early alarm reaction initiates the stress response, whereas resistance reflects continued activation as the person attempts to maintain functional balance. In the short term, that continuation may support coping and performance. If activation persists, however, physiological resources are consumed, creating conditions in which sleep, mood, immunity, and concentration may deteriorate.
Cortisol represents one of the stress hormones sustained during this phase. Its continued release reflects ongoing hypothalamic-pituitary-adrenal activity while the person adapts to persistent demands. The hormone is therefore part of the mechanism linking psychological stress with bodily regulation. When activation lasts too long, the associated physiological demand may contribute to problems involving sleep, mood, immunity, and concentration.
In psychological assessment, the model directs attention to both ongoing stress exposure and coping demands, not only to the presence of an initial stress reaction. Clinicians can consider whether persistent demands are accompanied by difficulties in sleep, mood, immunity, or concentration. This framing helps connect a person’s functioning with the duration and physiological burden of stress.
The concept helps explain why chronic stress may continue affecting a person after an immediate challenge has passed. It links persistent demands with sustained stress-system activity and the gradual consumption of physiological resources. In psychological research and practice, this connection provides a framework for examining coping over time and distinguishing temporary performance support from longer-lasting impairment.
Interventions informed by this model focus on reducing persistent stress exposure and addressing coping demands. The goal is not simply to describe the stress response, but to limit the conditions that keep sympathetic and hypothalamic-pituitary-adrenal activity engaged. This approach is relevant when ongoing activation is associated with impaired sleep, mood, immunity, or concentration, because those outcomes signal reduced adaptation.